Progressive Care Inc (fka RXMD)

[ndww42]

It is true that an R/S done right in conjunction with an uplist can have an absolutely bullish outcome.

Problem is I don't see that they did it right. I see the R/S as a way to reset the psychology of investors so they're confused about how much the shares are really worth now. All they see is the share price not the converted price.

Issue with RXMD has always been VOLUME. You need VOLUME whether the price is .005, .03 or $100 a share. You need actual buying with volume.

When this ran to .25 cents in 2018 that's now equivalent to around $50-55 a share.

Hopefully I'm wrong and my ignorance of this new company will allow this to fly from here.